Skip to main content
. 2014 Oct 2;121(3):413–422. doi: 10.1002/cncr.29030

Figure 1.

Figure 1

Search results for eligible phase 3 trials of epithelial ovarian cancer (EOC) performed between January 2000 and December 2010 are shown. RP3s indicates randomized phase 3 trials; ESMO, European Society for Medical Oncology; ASCO, American Society of Clinical Oncology; OS, overall survival; PFS, progression‐free survival; TTP, time to disease progression.